HSA — authorised 22 December 2008
- Marketing authorisation holder: LANTHEUS MEDCL
- Status: likely_approved
🇸🇬 GADOFOSVESET in Singapore
HSA authorised GADOFOSVESET on 22 December 2008
Marketing authorisation
GADOFOSVESET in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in Singapore
Frequently asked questions
Is GADOFOSVESET approved in Singapore?
Yes. HSA authorised it on 22 December 2008.
Who is the marketing authorisation holder for GADOFOSVESET in Singapore?
LANTHEUS MEDCL holds the Singaporean marketing authorisation.